نتایج جستجو برای: soluble cd30

تعداد نتایج: 90963  

Journal: :Haematologica 2013
Bettina Bisig Aurélien de Reyniès Christophe Bonnet Pierre Sujobert David S Rickman Teresa Marafioti Georges Delsol Laurence Lamant Philippe Gaulard Laurence de Leval

Peripheral T-cell lymphoma, not otherwise specified is a heterogeneous group of aggressive neoplasms with indistinct borders. By gene expression profiling we previously reported unsupervised clusters of peripheral T-cell lymphomas, not otherwise specified correlating with CD30 expression. In this work we extended the analysis of peripheral T-cell lymphoma molecular profiles to prototypical CD30...

Journal: :The Journal of clinical investigation 2017
Carlos A Ramos Brandon Ballard Huimin Zhang Olga Dakhova Adrian P Gee Zhuyong Mei Mrinalini Bilgi Meng-Fen Wu Hao Liu Bambi Grilley Catherine M Bollard Bill H Chang Cliona M Rooney Malcolm K Brenner Helen E Heslop Gianpietro Dotti Barbara Savoldo

BACKGROUND Targeting CD30 with monoclonal antibodies in Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) has had profound clinical success. However, adverse events, mainly mediated by the toxin component of the conjugated antibodies, cause treatment discontinuation in many patients. Targeting CD30 with T cells expressing a CD30-specific chimeric antigen receptor (CAR) may reduce ...

Journal: :Blood 2015
Katharina Blatt Sabine Cerny-Reiterer Juliana Schwaab Karl Sotlar Gregor Eisenwort Gabriele Stefanzl Gregor Hoermann Matthias Mayerhofer Mathias Schneeweiss Sylvia Knapp Thomas Rülicke Emir Hadzijusufovic Karin Bauer Dubravka Smiljkovic Michael Willmann Andreas Reiter Hans-Peter Horny Peter Valent

The Ki-1 antigen (CD30) is an established therapeutic target in patients with Hodgkin lymphoma and anaplastic large-cell lymphoma. We have recently shown that CD30 is expressed abundantly in the cytoplasm of neoplastic mast cells (MCs) in patients with advanced systemic mastocytosis (SM). In the current study, we asked whether CD30 is expressed on the surface of neoplastic MCs in advanced SM, a...

Journal: :Journal of immunology 1999
R Chiarle A Podda G Prolla E R Podack G J Thorbecke G Inghirami

The biological function of CD30 in the thymus has been only partially elucidated, although recent data indicate that it may be involved in negative selection. Because CD30 is expressed only by a small subpopulation of medullary thymocytes, we generated transgenic (Tg) mice overexpressing CD30 in T lymphocytes to further address its role in T cell development. CD30 Tg mice have normal thymic siz...

Journal: :European journal of histochemistry : EJH 2005
M Trovato M Grosso E Vitarelli M Le Donne V Barresi F Trimarchi G Barresi

In the present study, using immunohistochemistry, we studied the expression of CD30 and CD30-L in 35 deciduas obtained from women following elective abortion during normal physiological gestation and in 60 deciduas obtained from women after spontaneous abortion with or without signs of inflammation. The main difference was noticed in the first trimester of gestation in which was found a decreas...

Journal: :Journal of immunology 2004
Bruce R Blazar Robert B Levy Tak W Mak Angela Panoskaltsis-Mortari Hiromi Muta Monica Jones Melinda Roskos Jonathan S Serody Hideo Yagita Eckhard R Podack Patricia A Taylor

CD30, a TNFR family member, is expressed on activated CD4(+) and CD8(+) T cells and B cells and is a marker of Hodgkin's lymphoma; its ligand, CD30L (CD153) is expressed by activated CD4(+) and CD8(+) T cells, B cells, and macrophages. Signaling via CD30 can lead to proliferation or cell death. CD30-deficient (-/-) mice have impaired thymic negative selection and increased autoreactivity. Altho...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
Jörg Willers Reinhard Dummer Werner Kempf Thomas Kündig Günter Burg Marshall E Kadin

PURPOSE Cutaneous anaplastic large cell lymphomas (ALCLs) are characterized by the expression of CD30, spontaneous regression of skin lesions, and increased concentration of CD30 ligand (CD30L). We hypothesize that CD30-CD30L interactions explain the unusual clinical behavior of cutaneous ALCLs. EXPERIMENTAL DESIGN Eight lymphoma cell lines established from four different patients were analyz...

2017
Angela C. Zhou Laura M. Snell Michael E. Wortzman Tania H. Watts

CD30 is a tumor necrosis factor receptor (TNFR) family member whose expression is associated with Hodgkin's disease, anaplastic large cell lymphomas, and other T and B lymphoproliferative disorders in humans. A limited number of studies have assessed the physiological role of CD30/CD30 ligand interactions in control of infection in mice. Here, we assess the role of CD30 in T-cell immunity to ac...

Behrouz Gharesi-Fard, Hossein Haghbin Jaleh Zolghadri Leila Jafarzadeh

Background: Normal pregnancy is thought to be dependent on Th2 deviation, while Recurrent Pregnancy Loss (RPL) and Pre-eclampsia (PE) appear to be biased toward the Th1 immune response. It is believed that the soluble form of CD30 (sCD30) is an index of Th2 immune response or modulator of Th1/Th2 responses. Objective: The aim of this study was determination of the sCD30 level in RPL and PE pati...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید